Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Ltd IPO

Asston Pharmaceuticals Ltd IPO Price Range is ₹115 - 123, with a minimum investment of ₹1,23,000 for 1000 shares.

₹1,23,000

/ 1000 shares

Minimum Investment

View Asston Pharmaceuticals Ltd IPO details including price range, minimum investment, lot size, financials, and IPO timeline. Get subscription updates, peer comparison, and key insights to help you make an informed decision.

IPO Status

Live

Price Band

₹115 - 123

Open Date

2025-07-09

Close Date

2025-07-11

IPO Size

₹27.56 Cr

Lot Size

1000 shares

Min Investment

₹1,23,000

Listing Exchange

BSE

Asston Pharmaceuticals Ltd IPO Application Timeline

upcoming
Open Date9 Jul 2025
Close Date11 Jul 2025
Allotment Date14 Jul 2025
Listing Date16 Jul 2025

Strengths and Risks

Strengths

Strengths

  • Formulation Expertise.

  • Experienced Promoters.

  • Wide range of Products.

  • Strategic Location.

  • Skilled Workforce.

  • Good relationship with contract manufacturers.

  • Quality Assurance.

  • Good relationship with clients in the export market.

  • Competitive Pricing.

  • Asset Light Model.


Risks

Risks

  • The Company operates in pharmaceutical sector, which is extensively regulated, any failures on its part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financial condition.

  • The company operate its own manufacturing facility for pharmaceutical products; however for certain products other than tablets, the company relies on third-party manufacturers to procure the pharmaceutical products.

  • The company depends on the success of its relationships with the company customers. The company derives a significant part of its revenue from its major customers and the company does not have long-term contracts with these customers other than contracts with 2 customers for one year. If one or more of such customers choose not to source their requirements from it, the company business, financial condition and results of operations may be adversely affected.

  • The loss of contract manufacturing tie-ups and the low entry barrier for contract manufacturing can affect production, order intake, revenue, cash flow, and profitability. The absence of exclusive agreements increases the risk of delays or disruptions in order execution, further impacting business operations.

  • The company has substantial working capital expenditure and may requires additional financing to meet those requirements and have risk of receivables, which could have an adverse effect on its results of operations and financial condition.

  • The property used by the Company for the purpose of its Registered Office and factory is not owned by the company. Any termination of the relevant lease agreement in connection with such property or the company failures to renew the same could adversely affect its operations.

  • The company success largely depends upon the knowledge and experience of its Promoters, Directors, the company Key Managerial Personnel and Senior Management as well as its ability to attract and retain personnel with technical expertise. Any loss of the company Promoter, Directors, Key Managerial Personnel, Senior Management or its ability to attract and retain them and other personnel with technical expertise could adversely affect its business, financial condition and results of operations.

  • If the company is not able to attract and retain sufficient qualified and trained personnel at the Company which may adversely affect its business.

  • The company has been recently converted into public limited company and any non-compliance with the provisions of Companies Act, 2013 may attract penalties against the Company which could impact its financial and operational performance and reputation.

  • All its manufacturing facilities are situated at Ambernath, Thane, Maharashtra resulting in concentration in a single region. Any interruption for a significant period of time, in these facilities may in turn adversely affect its business, financial condition and results of operations.

How to Apply for Asston Pharmaceuticals Ltd IPO on INDmoney

1

Download the INDmoney app and complete your KYC to open an account.

2

Go to the INDstocks section and tap on IPO, or search for ‘IPO’.

3

Select Asston Pharmaceuticals Ltd IPO from the list of live IPOs.

4

View key details like price band, lot size, and dates, then tap ‘Apply Now’.

5

Choose the number of lots and place your order via UPI.

6

Your funds will be blocked until the share allotment is finalized.

About Asston Pharmaceuticals Ltd

Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion), and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis. Our Company basically gives contract for manufacturing the products to WHO-GMP certified contract manufacturers and FDA-accredited laboratories, ensuring adherence to industry standards from production to export. From manufacturing to exports and distributions, our Company takes responsibility and oversees each phase of the supply chain.

Frequently Asked Questions of Asston Pharmaceuticals Ltd IPO

What is the size of the Asston Pharmaceuticals Ltd IPO?

The size of the Asston Pharmaceuticals Ltd IPO is ₹27.56 Cr.

What is the allotment date of the Asston Pharmaceuticals Ltd IPO?

Asston Pharmaceuticals Ltd IPO allotment date is Jul 14, 2025 (tentative).

What are the open and close dates of the Asston Pharmaceuticals Ltd IPO?

The Asston Pharmaceuticals Ltd IPO will open on Jul 9, 2025 and close on Jul 11, 2025

What is the lot size of Asston Pharmaceuticals Ltd IPO?

The lot size for the Asston Pharmaceuticals Ltd IPO is 1000.

When will my Asston Pharmaceuticals Ltd IPO order be placed?

Your Asston Pharmaceuticals Ltd IPO order will be placed on Jul 9, 2025

Can we invest in Asston Pharmaceuticals Ltd IPO?

Yes, once Asston Pharmaceuticals Ltd IPO opens, you can invest in the shares of the company.

What would be the listing gains on the Asston Pharmaceuticals Ltd IPO?

The potential listing gains on the Asston Pharmaceuticals Ltd IPO will depend on various market factors and cannot be predicted with certainty.

What is 'pre-apply' for Asston Pharmaceuticals Ltd IPO?

'Pre-apply' for Asston Pharmaceuticals Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.